Sanofi SA
SNYHealthcare|Drug Manufacturers - General|France
$43.50
-0.40 (-0.91%)
DCF (FCF)
$57.37
Tangible Book
$1.80
Graham Number
$12.04
Earnings Power
$35.15
About
Sanofi develops and markets drugs with a concentration in immunology, vaccines, and rare diseases. Although the company offers a diverse array of drugs, its highest revenue generator, Dupixent, accounts for over 30% of total sales. Profits for this immunology blockbuster drug are shared with Regeneron. About 45% of total revenue comes from the United States, 20% from Europe, and 6% from China.
Stock Price
-11.8%(1Y)
Pipeline Summary
501 total trials87
Phase 1
149
Phase 2
124
Phase 3
90
Phase 4
Unknown: 13Completed: 366Terminated: 58Recruiting: 28ENROLLING_BY_INVITATION: 2Active: 17Withdrawn: 11NOT_YET_RECRUITING: 4APPROVED_FOR_MARKETING: 1NO_LONGER_AVAILABLE: 1
Active Trials (45)
A Study to Investigate the Efficacy and Safety of Frexalimab Versus Tacrolimus in Adults Undergoing Kidney Transplantation
NCT07412470Kidney Transplant Rejection
Phase 2Phase 3Recruiting
Enrollment: 526 participants
A Study to Describe the Real-world Effectiveness, Safety and Patterns of Use of Dupilumab in Patients With Chronic Spontaneous Urticaria
NCT07316114Chronic Spontaneous Urticaria
Recruiting
Enrollment: 400 participants
Efficacy and Safety of Subcutaneous Dupilumab in Participants With Asthma/Asthmatic Wheeze Aged 2 to <6 Years (LIBERTY ASTHMA TREKIDS)
NCT06191315Wheezing
Phase 3Recruiting
Enrollment: 90 participants
A Study of Dupilumab in Small Children With an Allergic Condition of the Esophagus (Food Pipe): Eosinophilic Esophagitis
NCT07112378Eosinophilic Esophagitis (EoE)
Phase 3Recruiting
Enrollment: 20 participants
Safety and Immunogenicity of an Investigational Pentavalent Meningococcal ABCYW Vaccine Against Meningococcal Disease in Children, Toddlers, and Infants
NCT06647407Meningococcal Immunization
Phase 1Phase 2Active
Enrollment: 750 participants
BioScore
5.3/10
Watchlist
Ownership
Recent News
2026-07-10 14:00:52
2026-07-10 13:26:33
2026-07-02 21:53:11
2026-06-30 05:58:10
2026-06-26 11:53:24
Data last updated: Jul 12, 2026, 07:24 PM